Abstract
The aim of this study was to establish the correlations between the polymorphisms of the genes interleukin (IL)-6 572, 190, and 174 in obese children. We assessed 222 hospitalized children divided into two groups: group I (control) included 110 patients with normal nutritional status, and group II consisted of 102 obesity patients. The two groups underwent IL-6 572 C/G, 190 C/T, and 174 G/C polymorphism testing, measurement of anthropometric parameters (mid-upper arm circumference and tricipital skinfold thickness), and paraclinical evaluation (protein, albumin, leptin, adiponectin, and vascular endothelial growth factor (VEGF)). We observed that phenotype CC was more frequent in obese children for IL-6 572 (p = 0.0001), whereas CG heterozygotes were more frequent in the obese group for the IL-6 190 gene (62.7 %; p = 0.0001). Leptin was dependent on IL-6 572 and IL-6 174 gene polymorphisms and albumin, whereas adiponectin was dependent on the IL-6 174 gene polymorphism. Body mass index (BMI), mid-upper arm circumference (MUAC), and tricipital skinfold thickness (TST) serum albumin levels correlated with C allele carriers of the IL-6 572 and IL-6 190 genes in children with obesity, whereas the CC genotype of IL-6 174 was a protective factor for obesity. Conclusion: Obesity is most frequently associated in children with IL-6 174 C allele carriers and with IL-6 190 C allele carriers.
Similar content being viewed by others
Abbreviations
- ADP:
-
Adiponectin
- ALAT:
-
Alanine aminotransferase
- ASAT:
-
Aspartate aminotransferase
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- EIA:
-
Enzyme immunoassay
- FTO:
-
Fat mass- and obesity-associated gene
- HDL:
-
High-density lipoprotein
- HDL-chol:
-
High-density lipoprotein cholesterol
- HBP:
-
High blood pressure
- IL-6:
-
Interleukin 6
- IL-8:
-
Interleukin 8
- LDL-chol:
-
Low-density lipoprotein cholesterol
- LDL:
-
Low-density lipoprotein
- MC2R gene:
-
Melanocortin 2 receptor gene
- MC3R gene:
-
Melanocortin 3 receptor gene
- MC4R gene:
-
Melanocortin 4 receptor gene
- MUAC:
-
Mid-upper arm circumference
- POMC:
-
Proopiomelanocortin
- PPAR γ2:
-
Peroxisome proliferator-activated receptor gamma
- SD:
-
Standard deviation
- SIM1:
-
Single-minded homologue
- T-Chol:
-
Total cholesterol
- TG:
-
Triglycerides
- TNF-α:
-
Tumor necrosis factor alpha
- TST:
-
Tricipital skinfold thickness
- VEGF:
-
Vascular endothelial growth factor
References
Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP, Navis G, Bakker SJ (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocrinol Metab 95(9):E26–E31
Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud’homme D, Despres JP, VohI MC (2003) The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48:14–19
Black PH (2003) The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 17(5):350–364, Review
Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117(6):241–250. doi:10.1055/s-0029-1192044
Böttcher Y, Körner A, Kovacs P, Kiess W (2012) Obesity genes: implication in childhood obesity. Paediatr Child Health 22(1):31–36
Cawley J, Meyerhoefer C (2012) The medical care costs of obesity: an instrumental variables approach. J Health Econ 31(1):219–230
Chesaru BI, Dobre M, Murariu G, Nechita A (2013) Risk for metabolic syndrome in a group of overweight children from South-East Romania. Rev Romana Med Lab 21(1):83–92. doi:10.2478/rrlm-2013-0021
Chirită EA, Puiu M, Gafencu M, Pienar C (2012) Growth references for school aged children in Western Romania. Acta Endocrinol (Copenh) 8(1):133–152. doi:10.4183/aeb.2012.133, Guidelines
Coșoveanu S, Bulucea D (2010) Study on the relationship between lifestyle and obesity in kindergarden and primary school children. Acta Med Marisiensis 56(4):322–324
Coşoveanu S, Bulucea D (2011) Obesity and overweight in children—epidemiology and etiopathogeny. Curr Health Sci J 37(2):101-5. http://www.chsjournal.org/archive/vol37-no2-2011/for-practitionerfor-practitioner/obesity-and-overweight-in-children-epidemiology-and-etiopathogeny, accessed 14 Sep 2013
Daneshmandi S, Pourfathollah AA, Pourpak Z, Heidarnazhad H, Kalvanagh PA (2012) Cytokine gene polymorphism and asthma susceptibility, progress and control level. Mol Biol Rep 39(2):1845–1853
Daniels SR, Greer FR, Committee on Nutrition (2008) Lipid screening and cardiovascular health in childhood. Pediatrics 122(1):198–208
Day FR, Loos RJF (2011) Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics 4:222–238. doi:10.1159/000332158
Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S (2010) Expression of inflammatory molecules and associations with BMI in children. Eur J Clin Investig 40(5):388–392. doi:10.1111/j.1365-2362.2010.02277.x
Dedoussis GVZ, Manios Y, Choumerianou DM, Yiannakouris N, Panagiotakos DB, Skenderi K, Zampelas A (2004) The IL-6 gene G 174C polymorphism related to health indices in Greek primary school children. Obes Res 12(7):1037e1041
Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W (2000) Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85(3):1334–1339
Fischer-Posovszky P, Moepps B, Lahr G, Strauss G, Barth TF, Kassubek J, Muhleder H, Moller P, Debatin KM, Gierschik P, Wabitsch M (2010) A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab 95(6):2836–2840. doi:10.1210/jc.2009-2466
Gahagan S (2011) Overweight and obesity. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE. Nelson’s textbook of pediatrics 19th Ed. Elsevier, Part VI, Nutrition, Cap. 44 179–88
Goyenechea E, Parra D, Martínez JA (2007) Impact of interleukin 6–174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 56(12):1643–1648
Grallert H, Huth C, Kolz M, Meisinger C, Herder C, Strassburger K, Giani G, Wichmann HE, Adamski J, Illig T, Rathmann W (2006) IL-6 promoter polymorphisms and quantitative traits related to the metabolic syndrome in KORA S4. Exp Gerontol 41(8):737–745
Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S (2005) Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 13(1):109–117
Hamdy O, Citkowitz E, Uwaifo GI, Oral EA, Griffing GT, Khardori R, Talavera F (2013) Obesity. http://emedicine.medscape.com/article/123702-overview#aw2aab6b2b3, accessed on 22 Jun 2013
Hamid YH, Rose CS, Urhammer SA, Glümer C, Nolsøe R, Kristiansen OP, Mandrup-Poulsen T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O (2005) Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48:e251–e260
Henningsson S, Håkansson A, Westberg L, Baghaei F, Rosmond R, Holm G, Ekman A, Nissbrandt H, Eriksson E (2006) Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity (Silver Spring) 14(11):1868–1873
Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6–174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22(24):2243–2252
Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, Langer B, Thorand B, Klopp N, Hamid YH, Pedersen O, Hansen T, Lyssenko V, Groop L, Meisinger C, Döring A, Löwel H, Lieb W, Hengstenberg C, Rathmann W, Martin S, Stephens JW, Ireland H, Mather H, Miller GJ, Stringham HM, Boehnke M, Tuomilehto J, Boeing H, Möhlig M, Spranger J, Pfeiffer A, Wernstedt I, Niklason A, López-Bermejo A, Fernández-Real JM, Hanson RL, Gallart L, Vendrell J, Tsiavou A, Hatziagelaki E, Humphries SE, Wichmann HE, Herder C, Illig T (2006) IL6 gene promoter polymorphisms and type 2 diabetes. Joint analysis of individual participants’ data from 21 studies. Diabetes 55:e2915–e2921
Illig T, Bongardt F, Schöpfer A, Müller-Scholze S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, Herder C, Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg (2004) Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 89(10):5053–5058, Erratum in: J Clin Endocrinol Metab. 90 (12):6385
IOTF-EASO 2005. EU platform on diet, physical activity and health, http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/iotf_en.pdf accessed on 16 Jul 2013
Jansson JO, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL, Wallenius V (2003) On the site and mechanism of action of the anti-obesity effects of interleukin-6. Growth Hormon IGF Res 13(Suppl A):S28–S32, Review
Kazumi T, Kawaguchi A, Hirano T, Yoshino G (2003) C-reactive protein in young, apparently healthy men: association with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52:1113–1116
Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100
Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30(9):1347–1355
Kipping R, Jago R, Lawlor D (2008) Childhood obesity in London “Obesity in children: Part 1: epidemiology, measurement, risk factors and screening. BMJ 337:a1824
Klipstein-Grobusch K, Mohlig M, Spranger J, Hoffmann K, Rodrigues FU, Sharma AM, Klaus S, Pfeiffer AF, Boeing H (2006) Interleukin-6 g-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study. Obesity (Silver Spring) 14:14–18
Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D (2007) Assessment of child and adolescent overweight and obesity. Pediatrics 120(Suppl 4):S193–S228
Kubaszek A, Pihlajamäki J, Punnonen K, Karhapää P, Vauhkonen I, Laakso M (2003) The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52(2):558–561
Loos RJ (2012) Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 26(2):211–226. doi:10.1016/j.beem.2011.11.003
Maachi M, Piéroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, Bastard JP (2004) Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28(8):993–997
Mantzouranis N, Pilianidis T, Douda H, Tokmakidis S (2008) Lifestyle study prevalence of childhood obesity: the Greek obesity and charts, and body mass index z-score values in the Centers for Disease Control and Prevention growth comparison of International Obesity Taskforce cutoffs. Pediatrics 121:S149. doi:10.1542/peds.2007-2022
Mărginean O, Pitea AM, Brânzaniuc K, Hutanu A, Voidăzan S (2010) Serum leptin levels in obese children and adolescents: relationship to age, gender, body mass index and lipid metabolism parameters. Rev Romana Med Lab 18(3):71–78
Mazen I, El-Gammal M, Abdel-Hamid M, Amr K (2009) A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol Genet Metab 97:305–308
Mendoza-Carrera F, Ramírez-López G, Ayala-Martínez NA, García-Zapién AG, Flores-Martínez SE, Sánchez-Corona J (2010) Influence of CRP, IL6, and TNFA gene polymorphisms on circulating levels of C-reactive protein in Mexican adolescents. Arch Med Res 41(6):472–477. doi:10.1016/j.arcmed.2010.08.015
Mocanu V (2013) Prevalence of overweight and obesity in urban elementary school children in Northeastern Romania: its relationship with socioeconomic status and associated dietary and lifestyle factors. BioMed Res Int. doi:10.1155/2013/537451
Möhlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, Bergmann MM, Ristow M, Hoffmann K, Pfeiffer AF (2004) Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 89(4):1885–1890
Popko K, Górska E, Pyrzak B, Telmaszczyk-Emmel A, Wisniewska A, Majcher A, Wasik M, Demkow U (2009) Influence of proinflammatory cytokine gene polymorphism on childhood obesity. Eur J Med Res 14(Suppl 4):59–62
Pyrzak B, Wisniewska A, Majcher A, Popko K, Wasik M, Demkow U (2009) Association between metabolic disturbances and G-174C polymorphism of interleukin-6 gene in obese children. Eur J Med Res 14(suppl IV):196–200
Ramírez-López G, Portilla-de Buen E, Sánchez-Corona J, Salmerón-Castro J, Mendoza-Carrera F (2013) Interleukin-6 polymorphisms are associated with obesity and hyperglycemia in Mexican adolescents. Arch Med Res 44(1):62–68. doi:10.1016/j.arcmed.2012.10.019
Rostami F, Haj Hosseini R, Sharifi K, Daneshpour M, Azizi F, Hedayati M (2010) Association of G-174C polymorphism of the interleukin-6 Gene promoter with obesity in Iranian population. World Acad Sci Technol 45:99–102
Saxena M, Srivastava N, Banerjee M (2013) Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus. Mol Biol Rep 40(11):6271–6279. doi:10.1007/s11033-013-2739-4
Schwarz SM (2013) Obesity in children. http://emedicine.medscape.com/article/985333-medication#3. Accessed 18 Feb.2014
Schwiebbe L, Talma H, van Mil EG, Fetter WP, Hirasing RA, Renders CM (2013) Diagnostic procedures and treatment of childhood obesity by pediatricians. Health Policy 111(2):110–115. doi:10.1016/j.healthpol.2013.04.008
Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X, Jansson PA, Smith U (2004) High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12(3):454–461
Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE (2004) A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab 82(2):180–186. doi:10.1016/j.ymgme.2004.04.001
Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138–18144
Văleanu C, Tătar S, Nanulescu M, Leucuta A, Ichim G (2009) Prevalence of obesity and overweight among school children in Cluj Napoca. Acta Endocrinol (Copenh) 5(2):213–219
Yang X, Feng L, Li C, Li Y (2014) Association of IL-6−174G/ C and−572C/ G polymorphisms with risk of young ischemic stroke patients. Gene 539:258–262
Zhang D, Zhou Y, Wu L, Wang S, Zheng H, Yu B, Li J (2008) Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer. Ann Clin Lab Sci 38(2):113–119
Zhangbin Y, Shuping H, Xingguo C, Chun Z, Xuejie W, Xirong G (2011) Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity 20:396–406. doi:10.1038/oby.2011.148
Acknowledgments
The English proofreading was managed by Professional Editing Services via spi-global.com (www.prof-editing.com). This work was supported by Internal Research Grants (Project No. 19/11.12.2013) from the University of Medicine and Pharmacy Tirgu Mures, Romania.
Conflict of interest
None of the authors have any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Peter de Winter
Rights and permissions
About this article
Cite this article
Oana, M.C., Claudia, B., Carmen, D. et al. The role of IL-6 572 C/G, 190 C/T, and 174 G/C gene polymorphisms in children’s obesity. Eur J Pediatr 173, 1285–1296 (2014). https://doi.org/10.1007/s00431-014-2315-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2315-5